Furthermore, since enumeration of CD4+ and CD8+ T cell subsets in COVID-19 patients is not consistently accompanied by further in-depth phenotypic information, it is not clear whether reduced numbers of specific populations are due to conversions between particular phenotypes in the respective subset, or outright loss of cells [99, 120]. The gene discussed is CD4; the disease is COVID-19.